日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Erwinia tasmaniensis ATP synthase subunit beta (atpD) CSB-YP002350ENB
CSB-EP002350ENB
CSB-BP002350ENB
CSB-MP002350ENB
CSB-EP002350ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis S-adenosylmethionine decarboxylase proenzyme (speD) CSB-YP001658ENB
CSB-EP001658ENB
CSB-BP001658ENB
CSB-MP001658ENB
CSB-EP001658ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Queuine tRNA-ribosyltransferase (tgt) CSB-YP019146ENB
CSB-EP019146ENB
CSB-BP019146ENB
CSB-MP019146ENB
CSB-EP019146ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia tasmaniensis Cysteine desulfurase (iscS) CSB-YP015769ENB
CSB-EP015769ENB
CSB-BP015769ENB
CSB-MP015769ENB
CSB-EP015769ENB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cricetulus griseus Golgi pH regulator (GPR89), partial CSB-YP009840DXU
CSB-EP009840DXU
CSB-BP009840DXU
CSB-MP009840DXU
CSB-EP009840DXU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia pipientis subsp. Culex pipiens ATP synthase subunit a (atpB), partial CSB-YP015070WBO
CSB-EP015070WBO
CSB-BP015070WBO
CSB-MP015070WBO
CSB-EP015070WBO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia pipientis subsp. Culex pipiens Methionyl-tRNA formyltransferase (fmt) CSB-YP015150WBO
CSB-EP015150WBO
CSB-BP015150WBO
CSB-MP015150WBO
CSB-EP015150WBO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia pipientis subsp. Culex pipiens Nucleoside diphosphate kinase (ndk) CSB-YP015889WBO
CSB-EP015889WBO
CSB-BP015889WBO
CSB-MP015889WBO
CSB-EP015889WBO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia pipientis subsp. Culex pipiens Thymidylate kinase (tmk) CSB-YP007226WBO
CSB-EP007226WBO
CSB-BP007226WBO
CSB-MP007226WBO
CSB-EP007226WBO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wolbachia pipientis subsp. Culex pipiens Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) CSB-YP022917WBO
CSB-EP022917WBO
CSB-BP022917WBO
CSB-MP022917WBO
CSB-EP022917WBO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Orientia tsutsugamushi Thymidylate kinase (tmk) CSB-YP007226OEV
CSB-EP007226OEV
CSB-BP007226OEV
CSB-MP007226OEV
CSB-EP007226OEV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Orientia tsutsugamushi ATP synthase subunit delta (atpH) CSB-YP002355OEV
CSB-EP002355OEV
CSB-BP002355OEV
CSB-MP002355OEV
CSB-EP002355OEV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Orientia tsutsugamushi Elongation factor G (fusA), partial CSB-YP009373OEV
CSB-EP009373OEV
CSB-BP009373OEV
CSB-MP009373OEV
CSB-EP009373OEV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Orientia tsutsugamushi Ribosome-recycling factor (frr) CSB-YP014941OEV
CSB-EP014941OEV
CSB-BP014941OEV
CSB-MP014941OEV
CSB-EP014941OEV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Transcription factor Sox-18 (sox18) CSB-YP022425XBF
CSB-EP022425XBF
CSB-BP022425XBF
CSB-MP022425XBF
CSB-EP022425XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Pre-B-cell leukemia transcription factor 2 (pbx2) CSB-YP017506XBF
CSB-EP017506XBF
CSB-BP017506XBF
CSB-MP017506XBF
CSB-EP017506XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylacidiphilum infernorum Methionyl-tRNA formyltransferase (fmt) CSB-YP015150MSV
CSB-EP015150MSV
CSB-BP015150MSV
CSB-MP015150MSV
CSB-EP015150MSV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylacidiphilum infernorum tRNA dimethylallyltransferase (miaA) CSB-YP024529MSV
CSB-EP024529MSV
CSB-BP024529MSV
CSB-MP024529MSV
CSB-EP024529MSV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylacidiphilum infernorum Queuine tRNA-ribosyltransferase (tgt) CSB-YP019146MSV
CSB-EP019146MSV
CSB-BP019146MSV
CSB-MP019146MSV
CSB-EP019146MSV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylacidiphilum infernorum Glycine cleavage system H protein (gcvH) CSB-YP009335MSV
CSB-EP009335MSV
CSB-BP009335MSV
CSB-MP009335MSV
CSB-EP009335MSV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×